Reversible Immunoaffinity Interface Enables Dynamic Manipulation of Trapping Force for Accumulated Capture and Efficient Release of Circulating Rare Cells

Adv Sci (Weinh). 2021 Oct;8(20):e2102070. doi: 10.1002/advs.202102070. Epub 2021 Sep 2.

Abstract

Controllable assembly and disassembly of recognition interface are vital for bioanalysis. Herein, a strategy of dynamic manipulation of trapping force by engineering a dynamic and reversible immunoaffinity microinterface (DynarFace) in a herringbone chip (DynarFace-Chip) for liquid biopsy is proposed. The DynarFace is assembled by magnetically attracting immunomagnetic beads (IMBs) on chip substrate, with merits of convenient operation and reversible assembly. The DynarFace allows accumulating attachment of IMBs on circulating rare cell (CRC) surfaces during hydrodynamically enhanced interface collision, where accumulatively enhanced magnetic trapping force improves capture efficiency toward CRCs with medium expression of biomarkers from blood samples by 134.81% compared with traditional non-dynamic interfaces. Moreover, magnet withdrawing-induced disappearance of trapping force affords DynarFace disassembly and CRC release with high efficiency (>98%) and high viability (≈98%), compatible with downstream in vitro culture and gene analysis of CRCs. This DynarFace strategy opens a new avenue to accumulated capture and reversible release of CRCs, holding great potential for liquid biopsy-based precision medicine.

Keywords: circulating tumor cells; dynamic manipulation; liquid biopsy; microfluidics; reversible interface.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / blood*
  • Cell Line, Tumor
  • Cell Separation / methods
  • Cell Survival / genetics
  • Humans
  • Immunomagnetic Separation / methods
  • Liquid Biopsy
  • Microfluidics
  • Neoplasms / blood*
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Neoplastic Cells, Circulating*
  • Precision Medicine
  • Trophoblasts / pathology

Substances

  • Biomarkers, Tumor